Evidence map›Paper›PMID 37552690›Full record

ArticlePLoS biology2023

Lmo4 synergizes with Fezf2 to promote direct in vivo reprogramming of upper layer cortical neurons and cortical glia towards deep-layer neuron identities.

Torsten Felske, Chiara Tocco, Sophie Péron, Kawssar Harb, Christian Alfano, Chiara Galante, Benedikt Berninger, Michèle Studer

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Torsten FelskeUniversité Côte d'Azur, CNRS, Inserm, iBV, Nice, France.
Chiara ToccoUniversité Côte d'Azur, CNRS, Inserm, iBV, Nice, France.
Sophie PéronResearch Group "Adult Neurogenesis and Cellular Reprogramming", Institute of Physiological Chemistry, University Medical Center Johannes Gutenberg University, Mainz, Germany.
Kawssar HarbUniversité Côte d'Azur, CNRS, Inserm, iBV, Nice, France.
Christian AlfanoUniversité Côte d'Azur, CNRS, Inserm, iBV, Nice, France.
Chiara GalanteResearch Group "Adult Neurogenesis and Cellular Reprogramming", Institute of Physiological Chemistry, University Medical Center Johannes Gutenberg University, Mainz, Germany.
Benedikt BerningerResearch Group "Adult Neurogenesis and Cellular Reprogramming", Institute of Physiological Chemistry, University Medical Center Johannes Gutenberg University, Mainz, Germany.
Michèle StuderUniversité Côte d'Azur, CNRS, Inserm, iBV, Nice, France.ORCID 0000-0001-7105-2957
Centre National de la Recherche Scientifique · FRKing's College London · GBJohannes Gutenberg University Mainz · DE

Funding

Wellcome Trust 206410/Z/17/Z
6 · The paper itself

Abstract

In vivo direct neuronal reprogramming relies on the implementation of an exogenous transcriptional program allowing to achieve conversion of a particular neuronal or glial cell type towards a new identity. The transcription factor (TF) Fezf2 is known for its role in neuronal subtype specification of deep-layer (DL) subcortical projection neurons. High ectopic Fezf2 expression in mice can convert both upper-layer (UL) and striatal projection neurons into a corticofugal fate, even if at low efficiency. In this study, we show that Fezf2 synergizes with the nuclear co-adaptor Lmo4 to further enhance reprogramming of UL cortical pyramidal neurons into DL corticofugal neurons, at both embryonic and early postnatal stages. Reprogrammed neurons express DL molecular markers and project toward subcerebral targets, including thalamus, cerebral peduncle (CP), and spinal cord (SC). We also show that co-expression of Fezf2 with the reprogramming factors Neurog2 and Bcl2 in early postnatal mouse glia promotes glia-to-neuron conversion with partial hallmarks of DL neurons and with Lmo4 promoting further morphological complexity. These data support a novel role for Lmo4 in synergizing with Fezf2 during direct lineage conversion in vivo.

Indexed as

DNA-Binding ProteinsNeuronsAdaptor Proteins, Signal TransducingAnimalsBasic Helix-Loop-Helix ProteinsLIM Domain ProteinsMiceNerve Tissue ProteinsNeurogliaPyramidal CellsTranscription FactorsAdaptor Proteins, Signal TransducingBasic Helix-Loop-Helix ProteinsDNA-Binding ProteinsLIM Domain ProteinsLmo4 protein, mouseNerve Tissue ProteinsNeurog2 protein, mouseTranscription FactorsZfp312 protein, mouse

Identifiers

PMID37552690
PMCPMC10409279
OpenAlexW4385654954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.